AFT Pharmaceuticals (NZE:AFT, ASX:AFP) expects to incur an operating loss of below NZ$2 million for the six months ended Sept. 30, according to a Friday filing with the New Zealand bourse.
The pharmaceuticals company attributed the first-half loss to lower sales amid a reduction in orders from large customers and a doctors' strike in South Korea, among other factors.
AFT will report its interim results on Nov. 21.
The company's shares were down more than 8% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.